Physician

Arati Chepur Patel, MD

According to 2025 Medicare claims, Arati Patel, MD (NPI: 1356395388) practices hematology/oncology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from Calvert, MD. This provider's primary affiliated billing organization is CALVERTHEALTH MEDICAL GROUP, LLC (NPI: 1386871390; TIN: 263828176) and primary practice location at 20678-4043.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 65,640 HCPCS/CPT codes, and received $908,878 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 603 prescription claims across 135 beneficiaries totaling $823,307 in drug costs, led by Verzenio (Abemaciclib). 2023 DME data shows 31 claims. Open Payments data shows 1 records totaling $108. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $402,658 to $908,878. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $281,040 and ending at $823,307. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,318 and ending at $2,135.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	390	23,808	$402,658
2016	404	31,659	$511,503
2017	377	30,314	$435,853
2018	436	61,052	$1,025,941
2019	498	83,555	$1,036,044
2020	524	117,140	$1,329,888
2021	496	90,281	$1,079,412
2022	517	89,508	$877,288
2023	460	69,699	$945,870
2024	482	65,640	$908,878

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	88	504	$281,040
2016	96	511	$354,890
2017	75	392	$627,950
2018	99	491	$778,355
2019	113	565	$1,011,899
2020	99	407	$808,177
2021	104	436	$743,912
2022	112	511	$736,366
2023	117	487	$395,858
2024	135	603	$823,307

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	43	$28,756
2016	32	50	$6,363
2017	N/R	38	$1,344
2018	15	34	$6,149
2019	N/R	N/R	N/R
2020	N/R	38	$2,986
2021	N/R	43	$3,523
2022	N/R	36	$1,439
2023	N/R	31	$7,671
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	37	37	$172
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	132	251	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	272	345	$87
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	37	55	$46
96372	Injection of drug or substance under skin or into muscle	55	89	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	18	588	$278,728
Imbruvica	Ibrutinib	17	476	$273,430
Inrebic	Fedratinib Dihydrochloride	11	312	$201,887
Eliquis	Apixaban	19	885	$16,517
Exemestane	Exemestane	59	4,950	$9,735

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$108	Davol Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arati Chepur Patel, MD?

Tedicare shows public-source Medicare data for Arati Chepur Patel, MD (NPI 1356395388), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arati Chepur Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arati Chepur Patel, MD?

Arati Chepur Patel, MD is linked to CALVERTHEALTH MEDICAL GROUP, LLC (billing NPI 1386871390) in the available physician profile data.

Does Arati Chepur Patel, MD have Open Payments data?

Arati Chepur Patel, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.